Penn analysis shows low risk of secondary cancers following CAR T cell therapy

The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, researchers from the Perelman School of Medicine at the University of Pennsylvania reported today in Nature Medicine.

Trinity Invests $25M Moxe Health for Health Data Interoperability

What You Should Know: – Trinity Capital Inc. (NASDAQ: TRIN), a leading provider of growth capital to innovative companies announced a $25M investment in Moxe

March 2, 2024

Drug-Gene Interactions: Minimizing Risk with Pharmacogenomics

Houda Hachad, PharmD, Vice President of Clinical Operations at Aranscia Every individual responds differently to medications, and their reactions can vary greatly. While a specific

August 10, 2023

Anesthesiologist Convicted; Oldest Conjoined Twins Die; ‘Donald Trump Did This’

Note that some links may require registration or subscription. Dallas anesthesiologist Raynaldo Rivera Ortiz Jr., MD, was convicted for injecting a nerve-blocking agent and other

April 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.